Mingde Biology (002932.SZ) released its half-year performance, with a net profit attributable to shareholders of 12.4973 million yuan, a year-on-year decrease of 80.82%.

Zhtng Cijng APP news, Mindray Bio-Medical (002932.SZ) has released its 2025 interim report. During the reporting period, the company achieved operating income of 139 million yuan, a year-on-year decrease of 9.71%. The net profit attributable to shareholders of the listed company was 12.4973 million yuan, a year-on-year decrease of 80.82%. The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 35.6218 million yuan, a 23.59% increase in losses compared to the same period last year. Basic earnings per share were 0.06 yuan.